IMI JU – Innovative Medicines Initiative Joint Undertaking

 http://www.imi.europa.eu/content/home

The four fields of research of the IMI JU

The IMI JU was created as a part of the "European Technology Platform" of FP6. This platform consists of various stakeholders, led on by the pharmaceutical industry. The IMI JU has four fields of research:

• Safety
• Efficacy
• Knowledge-Management
• Education and Training

The innovation of medicines is the core task of all IMI JU research projects. It is the aim of the IMI JU to develop new tools for more efficient research and development.

 Vision Document (2422 KB)

 Info Brochure (1888 KB) 

The IMI JU is a new form of partnership: public research institutions group with pharmaceutical companies. Thus, new constellations and networks develop. 

source: www.imi.europa.eu/content/mission

The financing of IMI JU projects consists of two parts:

• 1 billion Euro from FP7

• 1 billion Euro from the EFPIA (European Federation of Pharmaceutical Industries and Associations)
  

These 2 billion Euro are allocated for a time span of 9 years, from 2008 – 2017.

Further informationen

The current Calls are published on:  http://www.imi.europa.eu/content/call-proposals

The Calls are based on the  IMI JU Research Document (976 KB)

GABO:mi has profound experince with IMI JU projects:

• Project NEWMEDS (1. Call) www.newmeds-europe.com

• Project OncoTrack (2. Call) www.oncotrack.eu

• Project EU-AIMS (3. Call) www.eu-aims.eu